KMI will do better if oil gets strong. EPD will probably do better if oil declines. KMI is a better "growth" story than EPD, but it also carries a far greater risk. You pays ur money, and you takes ur chances.
Is there anyone who is not aware already well of Rayaldee's imminent approval? The whole world knows everything there is to know about it. Same story with 4Kscore when it was approved by Medicare and the insurance companies. None of this is new news. It's OLD news. It didn't matter then, and it won't matter this time either. It's not bad news; it's not good news. It's all fodder for the hypesters. The longs, whether they know it or not, are all waiting for the same thing; the news that Opko is being acquired at $47.75/share by some bigger fish in the pond. Some of us probably won't live long enough to see that day, but it seems highly likely it's coming. In the meantime, sit back and relax. Open a bottle of wine, and forget about Opko. Let Opko take care of itself. Patience will eventually pay off. I hope.
I could die at any moment, but I'll do so knowing that my daughter will reap the gain tax free. (She told me she's buying me a motorcycle that goes 150 MPH for Father's Day. She's also purposely neglecting to buy me a helmet.)
Buy it, hold it, die. In that order. Good quality MLPs should be bought with the intention of holding until you die. Your heirs get the stepped up cost basis, so the distributions end up being tax free. To do otherwise, you'll incur a huge tax burden that negates what makes MLPs attractive investments in the first place. This may seem obvious to some, but most people miss this simple rule. As always, talk to your friendly tax advisor to see whether an MLP is right for you.
The struggle to break decisively above $70 continues, but there's no way of knowing how many tries it'll take. I think it's inevitable that MMP will eventually move substantially higher. As long as they continue to increase the distribution, it's well worth the wait. The tax on the gain takes the decision away from me; I have to hold this until I die.
You're asking a hypothetical question to a hypothetical question. Opko is still very much a development-stage company with a very murky future. If and when it is acquired by a major pharma, the terms and price will reflect the perception of value at that time. The battery went dead in my crystal ball, so I can't help you. Sorry. However, I might be able to help you pick a winner in the fourth race at Monmouth Park Racetrack on Friday.
If the upcoming distribution is $0.395, then does that mean the following distribution will be $0.40? That would be almost the same as 40¢ per unit. I can't stand all this excitement and suspense.
I watch the prices I pay for fuel oil as an indicator of the future direction of MMP, and it has risen from $1.19 in mid-winter to $1.60 today. While I hate paying more for heating oil, I don't mind so much on days like today. In fact, I'd be even happier if it went back to $4 where it was in 2014.
Sadly for me, you're dead wrong. I've cut my (long) position, but I still hold a modest number of shares. Actually, I almost never sell anything short. That's especially true when the overall short interest is as lop-sided as is Opko's. In this case, I feel that the shorts are playing an incredibly dangerous game. I do keep an open sell order in above the market for the purpose of preventing my shares from being loaned, and suggest that all longs do the same. If my order ever goes off (which I highly doubt), I'd happily sell the last of my position.
If you missed the run-up and the collapse that followed it, you were among the lucky ones. OPK is right back where the BioRefLabs fiasco started. The lesson of OPK is to not get sucked in by the hype. If OPK ever proves to be a profitable investment, it will take many years of patience. Every catalyst that might light a fire under the stock is already well known and built into the price. It's now obvious that the BRLI acquisition was not the brilliant move that many hoped it would be. 4Kscore seems to be struggling. I seriously doubt that Rayaldee will have any dramatic effect on the stock price. I believe Frost's strategy is to gradually build up the portfolio of potential new products in the pipeline and then sell the whole company to a much larger player for a decent premium. Good luck on seeing that happen in the near future.
I wouldn't be surprised to see OPK selling in the $7 range again before it finds support. With so many dashed expectations, it's hard to rationalize the stock moving substantially higher than the lower end of the trading range until something positive erases this huge black eye. The aura of Frost's infallibility has finally been dealt a serious blow. From now on it will be almost impossible for him to regain any credibility without some sort of divine intervention. I'm not holding my breath on that happening anytime soon.
This is more than an embarrassment. It's a total fiasco! While it's not nearly as big a fiasco as the Bio Reference Labs debacle, it's still very serious nonetheless. Does Frost deserve his reputation as a brilliant strategist, or was he just extraordinarily lucky? It's beginning to look as if this company is run by a bunch of rank amateurs. It's entirely possible that his age is impairing his judgement, and he's putting too much confidence in his underlings to do the heavy lifting.
High expectations for Rayaldee are unwarranted. 4Kscore was over-hyped and turned out to be a big dud. Rayaldee will be more of the same. Lower your expectations, and you might be pleasantly surprised.... someday. However, I suspect that day is probably a long way off.